| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| BAD | BAK1 | ENSMFAP00000022365 | ENSMFAP00000013670 | BCL2 associated agonist of cell death. | BCL2 antagonist/killer 1. | 0.880 |
| BAD | BAX | ENSMFAP00000022365 | ENSMFAP00000020852 | BCL2 associated agonist of cell death. | BCL2 associated X, apoptosis regulator. | 0.770 |
| BAD | BCL2 | ENSMFAP00000022365 | ENSMFAP00000010439 | BCL2 associated agonist of cell death. | BCL2 apoptosis regulator. | 0.999 |
| BAD | BCL2L1 | ENSMFAP00000022365 | ENSMFAP00000026663 | BCL2 associated agonist of cell death. | BCL2 like 1. | 0.997 |
| BAD | BCL2L11 | ENSMFAP00000022365 | ENSMFAP00000043450 | BCL2 associated agonist of cell death. | Bcl-2-like protein 11; Induces apoptosis and anoikis. Belongs to the Bcl-2 family. | 0.959 |
| BAD | BID | ENSMFAP00000022365 | ENSMFAP00000027437 | BCL2 associated agonist of cell death. | BH3 interacting domain death agonist. | 0.874 |
| BAD | BIK | ENSMFAP00000022365 | ENSMFAP00000029041 | BCL2 associated agonist of cell death. | BCL2 interacting killer. | 0.581 |
| BAD | TP53 | ENSMFAP00000022365 | ENSMFAP00000038526 | BCL2 associated agonist of cell death. | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its intera [...] | 0.415 |
| BAK1 | BAD | ENSMFAP00000013670 | ENSMFAP00000022365 | BCL2 antagonist/killer 1. | BCL2 associated agonist of cell death. | 0.880 |
| BAK1 | BAX | ENSMFAP00000013670 | ENSMFAP00000020852 | BCL2 antagonist/killer 1. | BCL2 associated X, apoptosis regulator. | 0.961 |
| BAK1 | BCL2 | ENSMFAP00000013670 | ENSMFAP00000010439 | BCL2 antagonist/killer 1. | BCL2 apoptosis regulator. | 0.985 |
| BAK1 | BCL2L1 | ENSMFAP00000013670 | ENSMFAP00000026663 | BCL2 antagonist/killer 1. | BCL2 like 1. | 0.982 |
| BAK1 | BCL2L11 | ENSMFAP00000013670 | ENSMFAP00000043450 | BCL2 antagonist/killer 1. | Bcl-2-like protein 11; Induces apoptosis and anoikis. Belongs to the Bcl-2 family. | 0.847 |
| BAK1 | BECN1 | ENSMFAP00000013670 | ENSMFAP00000018770 | BCL2 antagonist/killer 1. | Beclin 1. | 0.470 |
| BAK1 | BID | ENSMFAP00000013670 | ENSMFAP00000027437 | BCL2 antagonist/killer 1. | BH3 interacting domain death agonist. | 0.997 |
| BAK1 | BIK | ENSMFAP00000013670 | ENSMFAP00000029041 | BCL2 antagonist/killer 1. | BCL2 interacting killer. | 0.681 |
| BAK1 | TP53 | ENSMFAP00000013670 | ENSMFAP00000038526 | BCL2 antagonist/killer 1. | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its intera [...] | 0.985 |
| BAX | BAD | ENSMFAP00000020852 | ENSMFAP00000022365 | BCL2 associated X, apoptosis regulator. | BCL2 associated agonist of cell death. | 0.770 |
| BAX | BAK1 | ENSMFAP00000020852 | ENSMFAP00000013670 | BCL2 associated X, apoptosis regulator. | BCL2 antagonist/killer 1. | 0.961 |
| BAX | BCL2 | ENSMFAP00000020852 | ENSMFAP00000010439 | BCL2 associated X, apoptosis regulator. | BCL2 apoptosis regulator. | 0.991 |
